Effects of tegaserod on Fos, substance P and calcitonin gene-related peptide expression induced by colon inflammation in lumbarsacral spinal cord

To investigate the mechanisms of tegaserod, a partial 5-HT4 agonist, in reducing visceral sensitivity by observing Fos, substance P (SP) and calcitonin gene-related peptide (CGRP) expression in the lumbarsacral spinal cord induced by colonic inflammation in rats. Twenty-four male rats with colonic i...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:World journal of gastroenterology : WJG 2004-06, Vol.10 (12), p.1830-1833
Hauptverfasser: Sun, Yi-Ning, Luo, Jin-Yan
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1833
container_issue 12
container_start_page 1830
container_title World journal of gastroenterology : WJG
container_volume 10
creator Sun, Yi-Ning
Luo, Jin-Yan
description To investigate the mechanisms of tegaserod, a partial 5-HT4 agonist, in reducing visceral sensitivity by observing Fos, substance P (SP) and calcitonin gene-related peptide (CGRP) expression in the lumbarsacral spinal cord induced by colonic inflammation in rats. Twenty-four male rats with colonic inflammation induced by intraluminal instillation of trinitrobenzenesulfonic acid (TNBS) were divided into 3 groups. Treatment group 1: intra-gastric administration of tegaserod, 2 mg/kg.d; Treatment group 2: intra-gastric administration of tegaserod, 1 mg/kg.d; intra-gastric administration of saline, 2.0 mL/d. After 7 d of intra-gastric administration, lumbarsacral spinal cord was removed and processed for Fos, SP and CGRP immunohistochemistry. In rats of the control group, the majority of Fos labeled neurons was localized in deeper laminae of the lumbarsacral spinal cord (L(5)-S(1)). SP and CGRP were primarily expressed in the superficial laminae of the spinal cord after TNBS injection. Intra-gastric administration of tegaserod (2 mg/kg.d) resulted in a significant decrease of Fos labeled neurons (22.0+/-7.7) and SP density (12.5+/-1.4) in the dorsal horn in the lumbarsacral spinal cord compared to those of the control group (62.2+/-18.9, 35.9+/-8.9, P0.05). Neither Fos expression nor SP or CGRP density in the dorsal horn significantly declined in rats of treatment group 2 compared to those of the control group (P>0.05). Tegaserod can significantly reduce Fos labeled neurons in the lumbarsacral spinal cord induced by colonic inflammation. Tegaserod may reduce visceral sensitivity by inhibiting SP expression in the dorsal horn of spinal cord.
doi_str_mv 10.3748/wjg.v10.i12.1830
format Article
fullrecord <record><control><sourceid>wanfang_jour_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4572280</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><wanfj_id>wjg200412030</wanfj_id><sourcerecordid>wjg200412030</sourcerecordid><originalsourceid>FETCH-LOGICAL-c487t-317c1d2b8c3fde247db87f9dfc301538b278e956cafb1732c34d3f4c7941bcb33</originalsourceid><addsrcrecordid>eNpVkctuFDEQRS0EIkNgzwp5gVjRgx_d2LNBiqIEkCLBAtaWH-XGo267sd0J-Qz-GA8z4rEq2ffWrSodhJ5TsuWil2_u9uP2tj0CZVsqOXmANozRXcdkTx6iDSVEdDvOxBl6UsqeEMb5wB6jMzpQKQcqNujnlfdga8HJ4wqjLpCTwyni61Re47KaUnW0gD9jHR22erKhphgiHiFCl2HSFRxeYKnBAYYfS4ZSQusP0a22SeYe2zT9_vCTnmddjyqe1tnoXLTNesJlCbEVm7J7ih55PRV4dqrn6Ov11ZfLD93Np_cfLy9uOttLUTtOhaWOGWm5d8B64YwUfue85YQOXBomJOyGt1Z7QwVnlveO-96KXU-NNZyfo3fH3GU1MzgLsbZN1JLDrPO9Sjqo_5UYvqkx3ap-EIxJ0gJeHgPudPQ6jmqf1tyuKKphYYT0lBF-sL06zcnp-wqlqjkUC9OkI6S1KNGsrB9oM5Kj0eZUSgb_ZxdK1AH3IVc13KrhVgfcreXFvzf8bTjx5b8Af8WrNg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>72002451</pqid></control><display><type>article</type><title>Effects of tegaserod on Fos, substance P and calcitonin gene-related peptide expression induced by colon inflammation in lumbarsacral spinal cord</title><source>MEDLINE</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Sun, Yi-Ning ; Luo, Jin-Yan</creator><creatorcontrib>Sun, Yi-Ning ; Luo, Jin-Yan</creatorcontrib><description>To investigate the mechanisms of tegaserod, a partial 5-HT4 agonist, in reducing visceral sensitivity by observing Fos, substance P (SP) and calcitonin gene-related peptide (CGRP) expression in the lumbarsacral spinal cord induced by colonic inflammation in rats. Twenty-four male rats with colonic inflammation induced by intraluminal instillation of trinitrobenzenesulfonic acid (TNBS) were divided into 3 groups. Treatment group 1: intra-gastric administration of tegaserod, 2 mg/kg.d; Treatment group 2: intra-gastric administration of tegaserod, 1 mg/kg.d; intra-gastric administration of saline, 2.0 mL/d. After 7 d of intra-gastric administration, lumbarsacral spinal cord was removed and processed for Fos, SP and CGRP immunohistochemistry. In rats of the control group, the majority of Fos labeled neurons was localized in deeper laminae of the lumbarsacral spinal cord (L(5)-S(1)). SP and CGRP were primarily expressed in the superficial laminae of the spinal cord after TNBS injection. Intra-gastric administration of tegaserod (2 mg/kg.d) resulted in a significant decrease of Fos labeled neurons (22.0+/-7.7) and SP density (12.5+/-1.4) in the dorsal horn in the lumbarsacral spinal cord compared to those of the control group (62.2+/-18.9, 35.9+/-8.9, P&lt;0.05). However, CGRP content in dorsal horn did not significantly reduce in rats of treatment group 1 (1.2+/-1.1) compared to that of the control group (2.8+/-2.4, P&gt;0.05). Neither Fos expression nor SP or CGRP density in the dorsal horn significantly declined in rats of treatment group 2 compared to those of the control group (P&gt;0.05). Tegaserod can significantly reduce Fos labeled neurons in the lumbarsacral spinal cord induced by colonic inflammation. Tegaserod may reduce visceral sensitivity by inhibiting SP expression in the dorsal horn of spinal cord.</description><identifier>ISSN: 1007-9327</identifier><identifier>EISSN: 2219-2840</identifier><identifier>DOI: 10.3748/wjg.v10.i12.1830</identifier><identifier>PMID: 15188517</identifier><language>eng</language><publisher>United States: Department of Gastroenterology,Second Hospital of Xi'an Jiaotong University, Xi'an 710004, Shaanxi Province, China</publisher><subject>Animals ; Brief Reports ; Calcitonin Gene-Related Peptide - metabolism ; Colitis - complications ; Colitis - drug therapy ; Colitis - metabolism ; Disease Models, Animal ; Gastrointestinal Agents - pharmacology ; Indoles - pharmacology ; Male ; Pain - drug therapy ; Pain - etiology ; Pain - metabolism ; Proto-Oncogene Proteins c-fos - metabolism ; Rats ; Rats, Sprague-Dawley ; Spinal Cord - drug effects ; Spinal Cord - metabolism ; Substance P - metabolism ; Visceral Afferents - drug effects ; Visceral Afferents - metabolism</subject><ispartof>World journal of gastroenterology : WJG, 2004-06, Vol.10 (12), p.1830-1833</ispartof><rights>Copyright © Wanfang Data Co. Ltd. All Rights Reserved.</rights><rights>The Author(s) 2004. Published by Baishideng Publishing Group Inc. All rights reserved. 2004</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c487t-317c1d2b8c3fde247db87f9dfc301538b278e956cafb1732c34d3f4c7941bcb33</citedby><cites>FETCH-LOGICAL-c487t-317c1d2b8c3fde247db87f9dfc301538b278e956cafb1732c34d3f4c7941bcb33</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Uhttp://www.wanfangdata.com.cn/images/PeriodicalImages/wjg/wjg.jpg</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4572280/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4572280/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,27903,27904,53769,53771</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15188517$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sun, Yi-Ning</creatorcontrib><creatorcontrib>Luo, Jin-Yan</creatorcontrib><title>Effects of tegaserod on Fos, substance P and calcitonin gene-related peptide expression induced by colon inflammation in lumbarsacral spinal cord</title><title>World journal of gastroenterology : WJG</title><addtitle>World J Gastroenterol</addtitle><description>To investigate the mechanisms of tegaserod, a partial 5-HT4 agonist, in reducing visceral sensitivity by observing Fos, substance P (SP) and calcitonin gene-related peptide (CGRP) expression in the lumbarsacral spinal cord induced by colonic inflammation in rats. Twenty-four male rats with colonic inflammation induced by intraluminal instillation of trinitrobenzenesulfonic acid (TNBS) were divided into 3 groups. Treatment group 1: intra-gastric administration of tegaserod, 2 mg/kg.d; Treatment group 2: intra-gastric administration of tegaserod, 1 mg/kg.d; intra-gastric administration of saline, 2.0 mL/d. After 7 d of intra-gastric administration, lumbarsacral spinal cord was removed and processed for Fos, SP and CGRP immunohistochemistry. In rats of the control group, the majority of Fos labeled neurons was localized in deeper laminae of the lumbarsacral spinal cord (L(5)-S(1)). SP and CGRP were primarily expressed in the superficial laminae of the spinal cord after TNBS injection. Intra-gastric administration of tegaserod (2 mg/kg.d) resulted in a significant decrease of Fos labeled neurons (22.0+/-7.7) and SP density (12.5+/-1.4) in the dorsal horn in the lumbarsacral spinal cord compared to those of the control group (62.2+/-18.9, 35.9+/-8.9, P&lt;0.05). However, CGRP content in dorsal horn did not significantly reduce in rats of treatment group 1 (1.2+/-1.1) compared to that of the control group (2.8+/-2.4, P&gt;0.05). Neither Fos expression nor SP or CGRP density in the dorsal horn significantly declined in rats of treatment group 2 compared to those of the control group (P&gt;0.05). Tegaserod can significantly reduce Fos labeled neurons in the lumbarsacral spinal cord induced by colonic inflammation. Tegaserod may reduce visceral sensitivity by inhibiting SP expression in the dorsal horn of spinal cord.</description><subject>Animals</subject><subject>Brief Reports</subject><subject>Calcitonin Gene-Related Peptide - metabolism</subject><subject>Colitis - complications</subject><subject>Colitis - drug therapy</subject><subject>Colitis - metabolism</subject><subject>Disease Models, Animal</subject><subject>Gastrointestinal Agents - pharmacology</subject><subject>Indoles - pharmacology</subject><subject>Male</subject><subject>Pain - drug therapy</subject><subject>Pain - etiology</subject><subject>Pain - metabolism</subject><subject>Proto-Oncogene Proteins c-fos - metabolism</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><subject>Spinal Cord - drug effects</subject><subject>Spinal Cord - metabolism</subject><subject>Substance P - metabolism</subject><subject>Visceral Afferents - drug effects</subject><subject>Visceral Afferents - metabolism</subject><issn>1007-9327</issn><issn>2219-2840</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVkctuFDEQRS0EIkNgzwp5gVjRgx_d2LNBiqIEkCLBAtaWH-XGo267sd0J-Qz-GA8z4rEq2ffWrSodhJ5TsuWil2_u9uP2tj0CZVsqOXmANozRXcdkTx6iDSVEdDvOxBl6UsqeEMb5wB6jMzpQKQcqNujnlfdga8HJ4wqjLpCTwyni61Re47KaUnW0gD9jHR22erKhphgiHiFCl2HSFRxeYKnBAYYfS4ZSQusP0a22SeYe2zT9_vCTnmddjyqe1tnoXLTNesJlCbEVm7J7ih55PRV4dqrn6Ov11ZfLD93Np_cfLy9uOttLUTtOhaWOGWm5d8B64YwUfue85YQOXBomJOyGt1Z7QwVnlveO-96KXU-NNZyfo3fH3GU1MzgLsbZN1JLDrPO9Sjqo_5UYvqkx3ap-EIxJ0gJeHgPudPQ6jmqf1tyuKKphYYT0lBF-sL06zcnp-wqlqjkUC9OkI6S1KNGsrB9oM5Kj0eZUSgb_ZxdK1AH3IVc13KrhVgfcreXFvzf8bTjx5b8Af8WrNg</recordid><startdate>20040615</startdate><enddate>20040615</enddate><creator>Sun, Yi-Ning</creator><creator>Luo, Jin-Yan</creator><general>Department of Gastroenterology,Second Hospital of Xi'an Jiaotong University, Xi'an 710004, Shaanxi Province, China</general><general>Baishideng Publishing Group Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>2B.</scope><scope>4A8</scope><scope>92I</scope><scope>93N</scope><scope>PSX</scope><scope>TCJ</scope><scope>5PM</scope></search><sort><creationdate>20040615</creationdate><title>Effects of tegaserod on Fos, substance P and calcitonin gene-related peptide expression induced by colon inflammation in lumbarsacral spinal cord</title><author>Sun, Yi-Ning ; Luo, Jin-Yan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c487t-317c1d2b8c3fde247db87f9dfc301538b278e956cafb1732c34d3f4c7941bcb33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Animals</topic><topic>Brief Reports</topic><topic>Calcitonin Gene-Related Peptide - metabolism</topic><topic>Colitis - complications</topic><topic>Colitis - drug therapy</topic><topic>Colitis - metabolism</topic><topic>Disease Models, Animal</topic><topic>Gastrointestinal Agents - pharmacology</topic><topic>Indoles - pharmacology</topic><topic>Male</topic><topic>Pain - drug therapy</topic><topic>Pain - etiology</topic><topic>Pain - metabolism</topic><topic>Proto-Oncogene Proteins c-fos - metabolism</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><topic>Spinal Cord - drug effects</topic><topic>Spinal Cord - metabolism</topic><topic>Substance P - metabolism</topic><topic>Visceral Afferents - drug effects</topic><topic>Visceral Afferents - metabolism</topic><toplevel>online_resources</toplevel><creatorcontrib>Sun, Yi-Ning</creatorcontrib><creatorcontrib>Luo, Jin-Yan</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Wanfang Data Journals - Hong Kong</collection><collection>WANFANG Data Centre</collection><collection>Wanfang Data Journals</collection><collection>万方数据期刊 - 香港版</collection><collection>China Online Journals (COJ)</collection><collection>China Online Journals (COJ)</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>World journal of gastroenterology : WJG</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sun, Yi-Ning</au><au>Luo, Jin-Yan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effects of tegaserod on Fos, substance P and calcitonin gene-related peptide expression induced by colon inflammation in lumbarsacral spinal cord</atitle><jtitle>World journal of gastroenterology : WJG</jtitle><addtitle>World J Gastroenterol</addtitle><date>2004-06-15</date><risdate>2004</risdate><volume>10</volume><issue>12</issue><spage>1830</spage><epage>1833</epage><pages>1830-1833</pages><issn>1007-9327</issn><eissn>2219-2840</eissn><abstract>To investigate the mechanisms of tegaserod, a partial 5-HT4 agonist, in reducing visceral sensitivity by observing Fos, substance P (SP) and calcitonin gene-related peptide (CGRP) expression in the lumbarsacral spinal cord induced by colonic inflammation in rats. Twenty-four male rats with colonic inflammation induced by intraluminal instillation of trinitrobenzenesulfonic acid (TNBS) were divided into 3 groups. Treatment group 1: intra-gastric administration of tegaserod, 2 mg/kg.d; Treatment group 2: intra-gastric administration of tegaserod, 1 mg/kg.d; intra-gastric administration of saline, 2.0 mL/d. After 7 d of intra-gastric administration, lumbarsacral spinal cord was removed and processed for Fos, SP and CGRP immunohistochemistry. In rats of the control group, the majority of Fos labeled neurons was localized in deeper laminae of the lumbarsacral spinal cord (L(5)-S(1)). SP and CGRP were primarily expressed in the superficial laminae of the spinal cord after TNBS injection. Intra-gastric administration of tegaserod (2 mg/kg.d) resulted in a significant decrease of Fos labeled neurons (22.0+/-7.7) and SP density (12.5+/-1.4) in the dorsal horn in the lumbarsacral spinal cord compared to those of the control group (62.2+/-18.9, 35.9+/-8.9, P&lt;0.05). However, CGRP content in dorsal horn did not significantly reduce in rats of treatment group 1 (1.2+/-1.1) compared to that of the control group (2.8+/-2.4, P&gt;0.05). Neither Fos expression nor SP or CGRP density in the dorsal horn significantly declined in rats of treatment group 2 compared to those of the control group (P&gt;0.05). Tegaserod can significantly reduce Fos labeled neurons in the lumbarsacral spinal cord induced by colonic inflammation. Tegaserod may reduce visceral sensitivity by inhibiting SP expression in the dorsal horn of spinal cord.</abstract><cop>United States</cop><pub>Department of Gastroenterology,Second Hospital of Xi'an Jiaotong University, Xi'an 710004, Shaanxi Province, China</pub><pmid>15188517</pmid><doi>10.3748/wjg.v10.i12.1830</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1007-9327
ispartof World journal of gastroenterology : WJG, 2004-06, Vol.10 (12), p.1830-1833
issn 1007-9327
2219-2840
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4572280
source MEDLINE; PubMed Central; Alma/SFX Local Collection
subjects Animals
Brief Reports
Calcitonin Gene-Related Peptide - metabolism
Colitis - complications
Colitis - drug therapy
Colitis - metabolism
Disease Models, Animal
Gastrointestinal Agents - pharmacology
Indoles - pharmacology
Male
Pain - drug therapy
Pain - etiology
Pain - metabolism
Proto-Oncogene Proteins c-fos - metabolism
Rats
Rats, Sprague-Dawley
Spinal Cord - drug effects
Spinal Cord - metabolism
Substance P - metabolism
Visceral Afferents - drug effects
Visceral Afferents - metabolism
title Effects of tegaserod on Fos, substance P and calcitonin gene-related peptide expression induced by colon inflammation in lumbarsacral spinal cord
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T18%3A15%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-wanfang_jour_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effects%20of%20tegaserod%20on%20Fos,%20substance%20P%20and%20calcitonin%20gene-related%20peptide%20expression%20induced%20by%20colon%20inflammation%20in%20lumbarsacral%20spinal%20cord&rft.jtitle=World%20journal%20of%20gastroenterology%20:%20WJG&rft.au=Sun,%20Yi-Ning&rft.date=2004-06-15&rft.volume=10&rft.issue=12&rft.spage=1830&rft.epage=1833&rft.pages=1830-1833&rft.issn=1007-9327&rft.eissn=2219-2840&rft_id=info:doi/10.3748/wjg.v10.i12.1830&rft_dat=%3Cwanfang_jour_pubme%3Ewjg200412030%3C/wanfang_jour_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=72002451&rft_id=info:pmid/15188517&rft_wanfj_id=wjg200412030&rfr_iscdi=true